ASA I or II
Showing 1 - 25 of >10,000
Multiple Myeloma in Relapse, Multiple Myeloma Progression, Multiple Myeloma Stage II Trial in London (Rivaroxaban, ASA)
Recruiting
- Multiple Myeloma in Relapse
- +5 more
-
London, Ontario, CanadaLondon Health Sciences Centre
Oct 3, 2022
Platelet Aggregation, Type 2 Diabetes, Aspirin Trial in Montréal (Aspirin 81Mg Ec Tab twice daily for 7 days, Aspirin 40Mg Chew
Not yet recruiting
- Platelet Aggregation
- +4 more
- Aspirin 81Mg Ec Tab twice daily for 7 days
- +2 more
-
Montréal, Quebec, CanadaMontreal Heart Institute
Jan 25, 2023
Melanoma (Skin) Trial in Salt Lake City (Aspirin 81 mg, Aspirin 325mg, Placebo oral tablet)
Completed
- Melanoma (Skin)
- Aspirin 81 mg
- +2 more
-
Salt Lake City, UtahHuntsman Cancer Institute/University of Utah
Feb 16, 2022
Polycythemia Vera Trial in Italy (AOP2014, Phlebotomies, ASA)
Active, not recruiting
- Polycythemia Vera
- AOP2014
- +2 more
-
San Giovanni Rotondo, (FG) Puglia, Italy
- +22 more
Jan 10, 2023
Mucopolysaccharidosis III-A Trial in Hamburg (JR-441)
Recruiting
- Mucopolysaccharidosis III-A
-
Hamburg, GermanyUniversitätsklinikum Hamburg-Eppendorf
Oct 18, 2023
Prostate Cancer Trial in Beijing, Shanghai (Phase I:[177Lu]Lu-XT033 Injection, Phase II:[177Lu]Lu-XT033 Injection)
Not yet recruiting
- Prostate Cancer
- Phase I:[177Lu]Lu-XT033 Injection
- Phase II:[177Lu]Lu-XT033 Injection
-
Beijing, Beijing, China
- +1 more
Oct 7, 2023
Osteoarthritis, Knee Trial in Taipei (2ccPA, Placebo)
Recruiting
- Osteoarthritis, Knee
- 2ccPA
- Placebo
-
Taipei, TaiwanTaipei Veterans General Hospital
Mar 28, 2023
Patients With Advanced Solid Tumors Trial in Beijing (TCC1727 tablet)
Not yet recruiting
- Patients With Advanced Solid Tumors
- TCC1727 tablet
-
Beijing, No.17, Panjiayuan Nanli, Chaoyang District, Beijing, ChinaCancer Hospital Chinese Academy of Medical Sciences
Jul 23, 2023
Advanced Solid Tumor Trial in Beijing (aPD1-MSLN-CAR T Cells)
Not yet recruiting
- Advanced Solid Tumor
- αPD1-MSLN-CAR T Cells
-
Beijing, ChinaNational Cancer Center Cancer Hospital Chinese Academy of Medica
Jul 13, 2023
Cytokine Storm Trial in Cairo (Non-Surgical periodontal therapy)
Completed
- Cytokine Storm
- Non-Surgical periodontal therapy
-
Cairo, EgyptFaculty of Dentistry-Ain Shams University
Sep 24, 2023
SARS-CoV-2 Trial in Chengdu (RBMRNA-176, Placebo)
Active, not recruiting
- SARS-CoV-2
- RBMRNA-176
- Placebo
-
Chengdu, Sichuan, ChinaChengdu Xinhua Hospital affiliated to North Sichuan Medical Coll
Jun 12, 2023
Airway Obstruction, Sedation Complication, Safety Issues Trial (Investigational device [I-IV], Comparator [I-IV])
Not yet recruiting
- Airway Obstruction
- +7 more
- Investigational device [I-IV]
- Comparator [I-IV]
- (no location specified)
Jan 31, 2023
Social Cognition, Facial Emotion Recognition, Facial Affect Trial in Amiens (Facial emotion recognition test)
Active, not recruiting
- Social Cognition
- +3 more
- Facial emotion recognition test
-
Amiens, FranceCHU Amiens
Jun 20, 2023
Periodontitis Trial in Turin (Repeated subgingival instrumentation, Supragingival scaling)
Recruiting
- Periodontitis
- Repeated subgingival instrumentation
- Supragingival scaling
-
Turin, ItalyCIR Dental School
May 26, 2023
Metastatic Clear Cell Renal Cell Carcinoma, With Positive PSMA Expression at Tumor Sites Trial (177Lu-PSMA-1
Not yet recruiting
- Metastatic Clear Cell Renal Cell Carcinoma
- With Positive PSMA Expression at Tumor Sites
- 177Lu-PSMA-1 (radiopharmaceutical)
- (no location specified)
Sep 26, 2023
Postoperative Pain, Postoperative Complications, Side Effect Trial in Van (Serratus anterior plane block, PECS I-II)
Recruiting
- Postoperative Pain
- +2 more
- Serratus anterior plane block
- PECS I-II
-
Van, TurkeyVan Yuzuncu Yil University
Jul 22, 2023
Advanced Malignancies Trial in Beijing (1A46 Drug Substance)
Not yet recruiting
- Advanced Malignancies
- 1A46 Drug Substance
-
Beijing, Beijing, ChinaBeijing Cancer Hospital
Aug 4, 2023
Overweight or Obesity Trial in Uppsala (Xenical® vs EMP 22, EMP 22 vs Xenical®, EMP 16 vs Xenical®)
Not yet recruiting
- Overweight or Obesity
- Xenical® vs EMP 22
- +2 more
-
Uppsala, SwedenCTC Clinical Trial Consultanta AB
Aug 25, 2023
Advanced Soft-tissue Sarcoma Trial (LB-100 plus Doxorrubicin, Doxorubicin)
Not yet recruiting
- Advanced Soft-tissue Sarcoma
- LB-100 plus Doxorrubicin
- Doxorubicin
- (no location specified)
Apr 11, 2023
GBM Trial in Nanjing (Postoperative radiotherapy for SVZ)
Recruiting
- GBM
- Postoperative radiotherapy for SVZ
-
Nanjing, Jiangsu, ChinaLining Guo
Oct 14, 2023
Breast Cancer Trial in Marseille (M1774, Fulvestrant injection)
Not yet recruiting
- Breast Cancer
- M1774
- Fulvestrant injection
-
Marseille, FranceInstitut Paoli Calmettes
Aug 9, 2023
Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell Trial in United Kingdom (ALETA-001)
Not yet recruiting
- Lymphoma, Non-Hodgkin
- +4 more
-
Birmingham, United Kingdom
- +5 more
Sep 18, 2023